MK-1064 is primarily utilized in the field of pharmaceutical research and development. It is investigated for its potential therapeutic applications, particularly in the treatment of neurological disorders. Researchers are exploring its efficacy in modulating specific receptors in the brain, which could lead to advancements in managing conditions such as insomnia, anxiety, and other sleep-related issues. Its role in preclinical studies highlights its significance in understanding and developing new treatments for central nervous system disorders.